Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- 52-wk high
- $42.50
- 52-wk low
- $14.19
- Prev close
- $27.90
- Mkt cap
- $6.43B
- P/E
- 2.4x
- Fwd P/E
- 47.6x
Smart money
Earnings
Earnings came in $0.53 a share below what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $216.8M | $292.9M | $216.2M | $263.7M |
| Cost of what it sold | $69.3M | $72.0M | $74.8M | $84.1M |
| Gross profit | $147.5M | $220.9M | $141.3M | $179.6M |
| What it spent | ||||
| Research and development | $21.6M | $31.8M | $5.4M | $32.4M |
| Sales and admin | $52.0M | $56.5M | $59.7M | $66.5M |
| Other operating costs | $41.3M | $44.2M | $71.0M | $53.8M |
| Total operating expenses | $114.9M | $132.5M | $136.1M | $152.7M |
| What was left | ||||
| Operating profit | $32.6M | $88.4M | $5.3M | $26.9M |
| Interest on debt | $13.5M | $11.4M | $12.8M | $9.2M |
| Profit before tax | $24.3M | $82.0M | -$644.0K | -$614.0K |
| Tax | — | — | -$134.0K | $23.0K |
| Net profit | $24.3M | $82.0M | -$510.0K | -$637.0K |
| EBITDA | $42.7M | $97.6M | $17.2M | $15.2M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
2 articles · 7 days
Coverage is mixed
Tone of tracked coverage
Caris Life Sciences (CAI) investors TSSP and Alan Waxman fall below 5% ownership
Leans bearishAug 7Caris Life Sciences Inc. (CAI) Stock Price | Live Quotes & Charts | NASDAQ
BullishAug 7